Abstract
The isolated occurrence of either congestive heart failure or ventricular tachycardia (VT) carries a poor prognosis. Frequently, congestive heart failure and complex ventricular arrhythmia coexist in patients (1–5). The combined occurrence of congestive heart failure and complex ventricular arrhythmia has a worse prognosis than either alone, with an annual reported mortality of between 50 and 60 percent (2). Previous attempts at extending survival in this group of patients has primarily focused on treatment of heart failure (1,2). Despite control of heart failure, mortality remained high as patients frequently succumbed to sudden death. However, previous investigators have not pursued aggressive arrhythmia management in this group of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Franciosa JA, Wilen M, Ziesche S, Cohn JN. Am J Cardiol 1983;51:831–836.
Wilson JR, Schwartz JS, St John Sutton M, Ferraro N, Horowitz LN, Reichek N, Josephson ME. J Am Coll Cardiol 1983;2:403–410.
Poll DS, Marchlinski FE, Buxton AE, Doherty JU, Waxman HL, Josephson ME. Circulation 1984;70:451–456.
Swerdlow CD, Winkle RA, Mason JW. N Engl J Med 1983;308:1436–1442.
Roy D, Waxman HL, Kienzle MG, Buxton AE, Marchlinski FE, Josephson ME. Am J Cardiol 1983;52:969–974.
Graboys TB, Lown B, Podrid PJ, DeSilva R. Am J Cardiol 1982;50:437–443.
Podrid P, Schoeneberger A, Lown B. N Engl J Med 1980;302:614.
Smitherman TC, Gottlich CM, Narahara KA, Osborn RC, Piatt M, Rude RE, Lepscomb K. Chest 1979;76:552–556.
Trobaugh GB, Kudenchuk PJ, Greene HI, Tutt RC, Kingston E, Gorham Jr, Gross BW, Graham EL, Sears GK, Werner, JA. Am J Cardiol 1984;54:1263–1266.
Stein J, Podrid P, Lown B. Am J Cardiol 1984;54:575–578.
McLeod AA, Stiles GL, and Shand, DG. J Pharmacol and Exp Therapeutics 1984;228:461–466.
Dukes ID, Vaughan Williams, EM. European Heart Journal 1984;5:115–125.
Walleffe A, Mary-Rabine L, de Rijbel R, Soyeur D, Legrand V,Kulbertus HE. European Heart Journal 1981;2:345–352.
Salerno DM, Granrud G, Sharkey P, Asinger R, Hodges M. Am J Cardiol 1984;53:77–83.
Shen EN, Sung RJ, Morady F, Schwartz AB, Scheinman MM, Dicarlo L, Shapiro W. J Am Coll Cardiol 1984;3:1291–1297.
Podrid PJ, Lown B. J Am Coll Cardiol 1984;4:117–125.
Baker BJ, Dinh HA, Kroskey D, de Soyza NDB, Murphy ML, Franciosa JA. Am J Cardiol 1984;54:20D–22D.
The Norwegian Multicenter Study Group. N Engl J Med 1981;304:801–807.
Coltart DJ, Gibson DG, Shand DG. British Med J 1971;1:490–491.
Brodsky MA, Sato DA, Allen BJ, Chesnie BN, Henry WL. Chest 1986;89:790–794.
Hirsowitz G, Podrid P, Lampert S, Stein J, Lown B: J Am Coll Cardiol 1978;3:618.
Swedberg K, Waagstein F, Hjalmarson A, Wallentin: Lancet 1979; 1:1374–375.
Wellens HJJ, Brugada P, Stevenson WG: Circulation 1985;72:1–7.
Swiryn S, Bauernfiend RA, Strasberg B, Palileo E, Iverson N, Levy PS, Rosen KM. Am Heart J 1982;104:43–50.
Horowitz LN, Josephson ME, Farshidi A, Spellman SR, Michelson EL, Greenspan AM. Circulation 1978;58:986–997.
Duffy CE, Swiryn S, Bauernfeind RA, Strasberg B, Pallileo E, Rosen KM. Am Heart J 1983;106:450–458.
Ross DL, Sze DY, Keefe DL, Swerdlow CD, Echt DS, Griffin JC, Winkle RA, Mason, JW. Circulation 1982;66: 1205–1210.
DiMarco J, Garan H, Ruskin J: Circulation 1980; 62:261.
Dreifus LS, Lim HR, Watanabe Y, McKnight E, Frank, Mn. JAMA 1968;204:736–737.
Fors WJ, Vanderark CR, Reynolds EW. Am J Cardiol 1971;27:190–194.
Mason JW, Winkle RA. Circulation 1978;58:971–985.
Wit AL, Hoffman BF, Rosen MR. (Parts A,B,C). Am Heart J 1975;90:521–523, 665–675, 795–03.
Arnsdorf MF. J Pharmacol and Exp Therapeutics 1977;201:689–700.
Han J, Garcia DP, Moe GK. Circulation Res 1964;14:516–524.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Brodsky, M.A., Allen, B.J., Luckett, C., Thomas, R. (1987). Antiarrhythmic Drug Therapy for Patients with Ventricular Tachyarrhythmias in the Setting of Left Ventricular Dysfunction: 1. The Role of Propafenone 2. The Role of Adjunct Beta-Blockade. In: Beamish, R.E., Panagia, V., Dhalla, N.S. (eds) Pharmacological Aspects of Heart Disease. Developments in Cardiovascular Medicine, vol 68. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2057-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2057-9_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9222-7
Online ISBN: 978-1-4613-2057-9
eBook Packages: Springer Book Archive